Kiniksa Pharmaceuticals International Plc (KNSA)
48.68
-0.36
(-0.72%)
USD |
NASDAQ |
Jun 09, 16:00
48.68
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International SG&A Expense (Quarterly) : 61.15M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 39.89M |
| Barinthus Biotherapeutics Plc | 2.524M |
| Aurinia Pharmaceuticals, Inc. | 22.03M |
| Adaptimmune Therapeutics Plc | 18.71M |
| Aptorum Group Ltd. | 0.2117M |